XML 47 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2013
Estimated Weighted Average Grant Date Fair Value per Share

The Company granted options and awards for 1,160,535 and 5,833 shares of common stock in the years ended December 31, 2013 and 2012, respectively. The fair values of the majority of employee stock options granted in the years ended December 31, 2013 and 2012 were estimated at the date of grant using the Black-Scholes model with the following assumptions and had the following estimated weighted average grant date fair value per share:

 

 

  

Years Ended December 31,

 

 

  

2013

 

 

2012

 

Expected term

  

 

5.8 years

  

 

 

5.3 years

  

Expected volatility

  

 

96

 

 

108

Risk-free interest rate

  

 

1.62

 

 

0.15

Expected dividend yield

  

 

0

 

 

0

Weighted-average grant date fair value per share

  

$

1.05

  

 

$

4.68

  

 

Summary of Stock Option Activities

A summary of ARCA’s stock option activities for the years ended December 31, 2013 and 2012, and related information as of December 31, 2013, is as follows:

 

 

  

For the years ended December 31,

 

 

  

2013

 

  

2012

 

 

  

Number of
Options

 

 

Weighted
Average
Exercise
Price

 

  

Number of
Options

 

 

Weighted
Average
Exercise
Price

 

Options outstanding, beginning of period

  

 

144,019

  

 

$

18.28

  

  

 

144,039

  

 

$

19.20

  

Granted

  

 

741,535

  

 

 

1.38

  

  

 

5,833

  

 

 

6.00

  

Exercised

  

 

 

 

 

  

  

 

 

 

 

  

Forfeited and cancelled

  

 

(42,112

 

 

11.62

  

  

 

(5,853

 

 

27.96

  

Options outstanding, end of period

  

 

843,442

  

 

$

3.76

  

  

 

144,019

  

 

$

18.28

  

Options exercisable, end of period

  

 

194,550

  

 

$

11.14

  

  

 

125,666

  

 

$

18.77

  

Options vested and expected to vest

  

 

832,941

  

 

$

3.78

  

  

 

 

 

 

 

 

 

 

Summary of Stock Options Outstanding and Exercisable

The following table summarizes information about stock options outstanding and exercisable as of December 31, 2013:

 

 

 

  

 

 

  

 

 

  

Options Outstanding

 

  

Options Exercisable

 

Range of Exercise Prices

 

  

Number
Outstanding

 

  

Weighted
Average
Remaining
Contractual
Term (in
years)

 

  

Weighted
Average
Exercise Price

 

  

Number
Exercisable

 

  

Weighted
Average
Exercise Price

 

$

0.36

  

 

  

  

$

1.33

  

  

 

1,433

  

  

 

8.56

  

  

$

1.21

  

  

 

286

  

  

$

0.71

  

 

1.38

  

 

  

  

 

1.38

  

  

 

727,869

  

  

 

9.46

  

  

 

1.38

  

  

 

98,233

  

  

 

1.38

  

 

1.40

  

 

  

  

 

22.98

  

  

 

96,465

  

  

 

5.85

  

  

 

12.04

  

  

 

78,356

  

  

 

13.18

  

 

22.98

  

 

  

  

 

33.42

  

  

 

17,168

  

  

 

4.42

  

  

 

32.78

  

  

 

17,168

  

  

 

32.78

  

 

33.42

  

 

  

  

 

440.40

  

  

 

250

  

  

 

0.33

  

  

 

263.94

  

  

 

250

  

  

 

263.94

  

 

440.40

  

 

  

  

 

1,908.00

  

  

 

257

  

  

 

0.30

  

  

 

1,443.56

  

  

 

257

  

  

 

1,443.56

  

 

 

  

 

 

 

  

 

 

 

  

 

843,442

  

  

 

8.94

  

  

$

3.76

  

  

 

194,550

  

  

$

11.14

  

 

Summary of RSU activity

A summary of RSU activity for the year ended December 31, 2013 is presented below:

 

Restricted Stock Awards

 

Number of
Shares

 

 

Weighted-
Average
Grant Date
Fair Value

 

Unvested RSUs at December 31, 2012

 

 

 

$

 

Granted

 

419,000

 

 

 

1.39

 

Vested

 

 

 

 

 

Forfeited and cancelled

 

 

 

 

 

Unvested RSUs at December 31, 2013

 

419,000

 

 

$

1.39

 

 

Non-Cash, Share-Based Compensation Expense

For the years ended December 31, 2013 and 2012 and for the period from Inception through December 31, 2013, the Company recognized the following non-cash, share-based compensation expense (in thousands):

 

 

  

Years Ended
December 31,

 

  

Period from
December 17, 2001
(date of inception)
to December 31,

 

 

  

2013

 

  

2012

 

  

2013

 

Research and Development

 

$

77

 

 

$

94

 

 

$

667

 

Selling, General and Administrative

 

 

206

 

 

 

212

 

 

 

1,817

 

Restructuring Expense

 

 

 

 

 

 

 

 

387

 

Total

 

$

283

 

 

$

306

 

 

$

2,871